Retrovirus-mediated gene transfer to tumors: utilizing the replicative power of viruses to achieve highly efficient tumor transduction in vivo.

Christopher R. Logg, Noriyuki Kasahara

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Vectors derived from retroviruses have been widely studied as tools for gene transfer into mammalian tissue in vivo. One application for which retroviral vectors have received particular attention is gene transfer into tumor cells for treatment of cancer. Simple retroviruses, such as murine leukemia virus (MLV), and the vectors derived from them, require cell division for infection and thus possess a degree of inherent specificity for the rapidly dividing cells of neoplastic tissue. This unique property and the ease with which retroviral vectors are manipulated and produced have provided much of the impetus for their use in experimental and clinical cancer gene-therapy studies.

Original languageEnglish (US)
Pages (from-to)499-525
Number of pages27
JournalMethods in molecular biology (Clifton, N.J.)
Volume246
StatePublished - 2004
Externally publishedYes

Fingerprint

Retroviridae
Viruses
Murine Leukemia Viruses
Neoplasm Genes
Genetic Therapy
Cell Division
Genes
Neoplasms
Infection
Therapeutics

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology

Cite this

@article{7ca250e8ef6d4635997be93215e4857c,
title = "Retrovirus-mediated gene transfer to tumors: utilizing the replicative power of viruses to achieve highly efficient tumor transduction in vivo.",
abstract = "Vectors derived from retroviruses have been widely studied as tools for gene transfer into mammalian tissue in vivo. One application for which retroviral vectors have received particular attention is gene transfer into tumor cells for treatment of cancer. Simple retroviruses, such as murine leukemia virus (MLV), and the vectors derived from them, require cell division for infection and thus possess a degree of inherent specificity for the rapidly dividing cells of neoplastic tissue. This unique property and the ease with which retroviral vectors are manipulated and produced have provided much of the impetus for their use in experimental and clinical cancer gene-therapy studies.",
author = "Logg, {Christopher R.} and Noriyuki Kasahara",
year = "2004",
language = "English (US)",
volume = "246",
pages = "499--525",
journal = "Methods in molecular biology (Clifton, N.J.)",
issn = "1064-3745",
publisher = "Humana Press",

}

TY - JOUR

T1 - Retrovirus-mediated gene transfer to tumors

T2 - utilizing the replicative power of viruses to achieve highly efficient tumor transduction in vivo.

AU - Logg, Christopher R.

AU - Kasahara, Noriyuki

PY - 2004

Y1 - 2004

N2 - Vectors derived from retroviruses have been widely studied as tools for gene transfer into mammalian tissue in vivo. One application for which retroviral vectors have received particular attention is gene transfer into tumor cells for treatment of cancer. Simple retroviruses, such as murine leukemia virus (MLV), and the vectors derived from them, require cell division for infection and thus possess a degree of inherent specificity for the rapidly dividing cells of neoplastic tissue. This unique property and the ease with which retroviral vectors are manipulated and produced have provided much of the impetus for their use in experimental and clinical cancer gene-therapy studies.

AB - Vectors derived from retroviruses have been widely studied as tools for gene transfer into mammalian tissue in vivo. One application for which retroviral vectors have received particular attention is gene transfer into tumor cells for treatment of cancer. Simple retroviruses, such as murine leukemia virus (MLV), and the vectors derived from them, require cell division for infection and thus possess a degree of inherent specificity for the rapidly dividing cells of neoplastic tissue. This unique property and the ease with which retroviral vectors are manipulated and produced have provided much of the impetus for their use in experimental and clinical cancer gene-therapy studies.

UR - http://www.scopus.com/inward/record.url?scp=1542740092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542740092&partnerID=8YFLogxK

M3 - Article

C2 - 14970613

AN - SCOPUS:1542740092

VL - 246

SP - 499

EP - 525

JO - Methods in molecular biology (Clifton, N.J.)

JF - Methods in molecular biology (Clifton, N.J.)

SN - 1064-3745

ER -